Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118434154 | 11843415 | 4 | F | 20150318 | 20160205 | 20151217 | 20160210 | EXP | CA-ROCHE-ITM201504IM012981 | ROCHE | 68.70 | YR | M | Y | 81.60000 | KG | 20160210 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118434154 | 11843415 | 1 | PS | ESBRIET | PIRFENIDONE | 1 | Oral | 1400633A | 22535 | 267 | MG | CAPSULE | TID | ||||||
| 118434154 | 11843415 | 2 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | 1400633A | 22535 | 267 | MG | CAPSULE | TID | ||||||
| 118434154 | 11843415 | 3 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | 1400633A | 22535 | 534 | MG | CAPSULE | TID | ||||||
| 118434154 | 11843415 | 4 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | 1400633A | 22535 | 801 | MG | CAPSULE | TID | ||||||
| 118434154 | 11843415 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 6 | C | ZENHALE | FORMOTEROL FUMARATEMOMETASONE FUROATE | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 7 | C | ASA | ASPIRIN | 1 | Unknown | 81 MG | 0 | 81 | MG | ||||||||
| 118434154 | 11843415 | 8 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 11 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 12 | C | GLUCONORM (CANADA) | REPAGLINIDE | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 13 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 118434154 | 11843415 | 14 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118434154 | 11843415 | 1 | Idiopathic pulmonary fibrosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118434154 | 11843415 | DE |
| 118434154 | 11843415 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118434154 | 11843415 | Ascites | |
| 118434154 | 11843415 | Death | |
| 118434154 | 11843415 | Epistaxis | |
| 118434154 | 11843415 | Hepatic enzyme increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118434154 | 11843415 | 1 | 20150109 | 0 | ||
| 118434154 | 11843415 | 2 | 20151026 | 0 | ||
| 118434154 | 11843415 | 3 | 20151103 | 0 | ||
| 118434154 | 11843415 | 4 | 20151130 | 0 |